FLGT
FLGT
NASDAQ · Health Care

Fulgent Genetics Inc

$23.74
+5.08 (+27.22%)
As of Nov 8, 10:24 PM ET ·
Financial Highlights (FY 2026)
Revenue
350.86M
Net Income
-65,799,167
Gross Margin
40.6%
Profit Margin
-18.8%
Rev Growth
-19.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 350.86M 435.95M 242.23M 275.80M
Gross Profit 142.31M 176.82M 95.53M 108.77M
Operating Income -109,852,785 -122,847,299 47.17M 53.86M
Net Income -65,799,167 -73,582,567 32.57M 36.27M
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Rev Growth -19.5% -19.5% -1.5% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 778.6K 778.6K 257.54M 237.86M
Total Equity 311.45M 311.45M 521.51M 552.15M
D/E Ratio 0.00 0.00 0.49 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -101,111,588 -119,353,887 59.74M 74.06M
Free Cash Flow — — 22.63M 30.51M